Thanks-neither this nor biotechs in general are my
Post# of 9122
looking forward to the day they are profitable so we have greater transparency and understanding of their success in getting their product into the mainstream
the biotech niche of the science world is not my gift either-partly because most biotech,like allopathic medicine in general- does not seek to solve the underlying problem-because such a solution would not be profitable to big pharma-
NNLX at least helps identify the problem BEFORE the patient is dead-which is always preferable to after the patient is dead in the world of allopathic triage (if allopathic medicine -in the solution phase presently monopolized by big pharma-put patients before profit, triage may not be necessary) so they can seek solutions and apparently in a more all-in cost effective manner which makes health care more affordable
I dont have much time to follow up on this so I appreciate whatever contributions people have to make-so I thank you and others for your contributions